You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 2, February 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  REVIEW ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Massive Hemoptysis in Cystic Fibrosis

Capt Donald K. Porter, MC, USAF; Capt Marvin J. Van Every, MC, USAF; Lt Col Raymond F. Anthracite, MC, USAF; Lt Col John W. Mack, Jr, MC, USAF

Arch Intern Med. 1983;143(2):287-290.


Abstract

• Massive hemoptysis occurs in 5% to 7% of patients with cystic fibrosis. Approximately 11% of these patients will die within 48 hours of manifestation because of uncontrolled hemoptysis and asphyxiation. If conservative medical treatment fails to control hemoptysis, fiberoptic or rigid bronchoscopy is the least risky and most accurate method of localizing the source of hemoptysis. Acute control of hemoptysis can be obtained in up to 100% of patients with endobronchial Fogarty balloon tamponade and in up to 88% of patients with bronchial artery embolization. Emergency thoracotomy can be performed if the above fail, but only in patients with mild cystic fibrosis and adequate pulmonary reserve.

(Arch Intern Med 1983;143:287-290)



Author Affiliations

From the Pulmonary Disease Service, Department of Medicine (Drs Porter and Anthracite), and the Department of Surgery (Drs Van Every and Mack), Wilford Hall USAF Medical Center (AFSC), Lackland AFB, Tex.


Footnotes

Accepted for publication July 12, 1982.

The opinions expressed are those of the authors and do not necessarily represent official USAF policy.

Reprint requests to Pulmonary Medical Service (SGHMMP), Wilford Hall Medical Center, Lackland AFB, TX 78236 (Dr Porter).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bronchial Artery Embolization for Hemoptysis in Young Patients with Cystic Fibrosis
Barben et al.
Radiology 2002;224:124-130.
ABSTRACT | FULL TEXT  

Bronchial Artery Embolization for the Management of Nonmassive Hemoptysis in Cystic Fibrosis
Antonelli et al.
Chest 2002;121:796-801.
ABSTRACT | FULL TEXT  

Use of Bilevel Positive Airway Pressure (BIPAP) in End-Stage Patients with Cystic Fibrosis Awaiting Lung Transplantation
Caronia et al.
CLIN PEDIATR 1998;37:555-559.
ABSTRACT  

Hemoptysis: A 10-Year Retrospective Study
Coss-Bu et al.
Pediatrics 1997;100:e7-e7.
ABSTRACT | FULL TEXT  

Massive Hemoptysis: Pathogenesis and Management
Winter and Ingbar
J Intensive Care Med 1988;3:171-188.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.